News On Japan

Over-the-Counter Drugs to Be Sold in Japan's Convenience Stores

TOKYO - The revised Pharmaceuticals and Medical Devices Act, passed by Japan's Upper House on May 14th, will allow over-the-counter drugs to be sold at convenience stores if consumers first receive online guidance from licensed pharmacists or other qualified professionals.

The reform also includes new measures to address the growing social issue of drug overdoses, particularly among young people. To curb misuse, the law will introduce age-related restrictions on the purchase of certain OTC medications.

Japan's regulation of pharmaceuticals dates back to the late 19th century, with the introduction of the "Regulations on Handling and Sales of Medicines" in 1889. This laid the groundwork for systematic control of drug safety and efficacy. In 1943, during the wartime period, the Pharmaceutical Affairs Law (PAL) was enacted to bring a more comprehensive legal framework to drug regulation. This law was overhauled in 1948 and again in 1960 in response to postwar public health needs and international developments. The 1960 version, known as Law No. 145, became the core legal structure for drug and medical device regulation in Japan for decades. It aimed to ensure the quality, efficacy, and safety of pharmaceuticals, cosmetics, and medical devices, and governed their manufacture, sale, labeling, and advertisement.

As medical technology and international regulatory standards advanced, so too did the need for Japan to modernize its pharmaceutical laws. One of the most significant reforms came in 2002, when the PAL was amended to introduce a risk-based classification system for medical devices. This shift aligned Japan’s system more closely with global norms and placed greater emphasis on post-marketing surveillance rather than just pre-approval inspections. The 2002 revision also acknowledged the growing complexity of biotechnology and the necessity of maintaining rigorous safety protocols even after products entered the market.

A decade later, in 2013, another sweeping amendment was made in response to the rapid development of regenerative medicine and biologics. This amendment introduced a new category for regenerative medical products and established a conditional, time-limited approval system that enabled earlier patient access to innovative therapies while still ensuring safety through follow-up monitoring. In recognition of the broader scope of products now covered by the legislation, the law was renamed the Pharmaceuticals and Medical Devices Act (PMD Act). This revision marked a turning point by officially including regenerative medicine under its jurisdiction, facilitating faster innovation cycles and supporting Japan's ambition to become a leader in advanced medical technology.

To support the implementation and oversight of these changes, the Japanese government established the Pharmaceuticals and Medical Devices Agency (PMDA) in 2004. The PMDA became the central body responsible for product review, safety monitoring, and post-market surveillance. It works in collaboration with the Ministry of Health, Labour and Welfare (MHLW) to ensure regulatory compliance and respond to emerging public health risks. Over the years, the PMDA has grown in capacity and international presence, playing a key role in global drug safety initiatives and harmonization efforts with counterparts such as the U.S. FDA and the European Medicines Agency.

The most recent revision in May 2025 focuses on expanding consumer access to over-the-counter (OTC) drugs while strengthening measures against misuse, particularly among young people. With the rise in convenience-focused retail and the increasing social issue of drug overdoses among youth, the government amended the PMD Act to allow sales of OTC drugs in convenience stores, on the condition that buyers first receive online explanations from licensed pharmacists. At the same time, the amendment introduces age-based restrictions on certain products to address concerns over abuse.

Source: Kyodo

News On Japan
POPULAR NEWS

A new urban forest featuring waterfalls, ponds, and seasonal greenery opened on November 20 in the redevelopment district north of JR Osaka Station, creating an 8,400-square-meter oasis in the heart of the city's bustling Umeda district.

Residents in Maebashi, Gunma Prefecture, remain on high alert ahead of a three-day weekend beginning November 21 as a mother bear believed to have been roaming residential neighborhoods since November 17 remains at large, with an expert warning that the animal may move north along a river and urging particular caution during the early morning and evening hours.

Nepalese police have detained 35 Japanese nationals and five Chinese nationals suspected of involvement in organized fraud operations at a mountain resort hotel near Kathmandu, where the group had allegedly established a sophisticated base equipped with a mock police station, photography studios and dozens of livestreaming booths.

A powerful surge of midwinter cold air is bringing heavy snow, strong winds and freezing temperatures to much of Japan ahead of the three-day holiday weekend beginning November 21st, with authorities warning of dangerous road conditions, possible landslides and traffic disruptions as snow and heavy rain continue along the Sea of Japan coast through the morning of November 22nd.

Japanese Prime Minister Sanae Takaichi held an unusually prolonged handshake with Chinese President Xi Jinping at the APEC summit in Shenzhen on November 19, speaking continuously for about 10 seconds as Xi nodded in response, while Japan sought to influence a historic three-way summit between the leaders of the United States, China and Russia scheduled for later in the day.

MEDIA CHANNELS
         

MORE Business NEWS

Honda unveiled its new Avancier SUV on November 20th, marking its entry into the large SUV segment with a three-row hybrid model scheduled to go on sale in Japan in spring 2027 as part of a broader effort to revive its automobile business.

Japan's rice harvest is expected to remain at a high level in 2026 despite prolonged rainfall and insufficient sunshine in some regions, with the Ministry of Agriculture, Forestry and Fisheries announcing on November 20 that production of rice for direct consumption is projected to reach 7.365 million tons.

Japan's Nikkei 225 plunged 3,008 points, or 5.06%, to close at 56,437 on Friday, November 20, its lowest level in more than seven months, as a global selloff in artificial intelligence and semiconductor stocks swept through Tokyo following a disappointing market reaction to Anthropic's initial public offering in the United States, triggering widespread selling that extended to banks, consumer stocks and other major industries.

Japan Tobacco (JT) has announced that it will exclude seven companies involved in its Russian operations from its consolidated financial statements after the Russian government placed the businesses under temporary administration, with the Japanese tobacco giant expecting to record losses of approximately 1.377 trillion yen.

Tokyo stocks closed higher on Thursday, November 19, 2026, with the Nikkei 225 gaining 419.93 points, or 0.71%, to finish at 59,444.21 at the 3:30 p.m. close, extending its rebound for a second consecutive session as expectations surrounding the record-breaking initial public offering of U.S. artificial intelligence developer Anthropic supported selected technology shares, although declines in Nvidia, copper prices and smaller growth stocks exposed continuing weakness across the broader market.

Japan's core machinery orders fell 0.3% in September from the previous month to 1.0662 trillion yen, marking the first decline in two months, although the government maintained its assessment that orders are showing signs of recovery.

Japan's Nikkei 225 rebounded on November 18 after two consecutive days of losses, closing 163.85 points higher, or 0.28%, at 59,024.28 at 3:30 p.m. Tokyo time, although an early rally driven by strong earnings from U.S. chipmaker Nvidia quickly lost momentum, leaving investors cautious about the outlook for artificial intelligence, technology valuations and the broader economy.

Japan recorded a trade deficit of 476.5 billion yen in October, marking the sixth consecutive month of red ink, as persistently high crude oil prices linked to prolonged instability in the Middle East pushed import costs higher, according to trade statistics released by the Finance Ministry on November 18th.